High expression of atypical protein kinase C λ/ι in gastric cancer as a prognostic factor for recurrence

Annals of Surgical Oncology

Volumn 17, Issue 1, 2010, Pages 81-88

  Takagawa, Ryo ^a   Akimoto, Kazunori ^a   Ichikawa, Yasushi ^a   Akiyama, Hirotoshi ^a   Kojima, Yasuyuki ^a   Ishiguro, Hitoshi ^a,b   Inayama, Yoshiaki ^c   Aoki, Ichiro ^a,d   Kunisaki, Chikara ^e   Endo, Itaru ^a   Nagashima, Yoji ^a,d   Ohno, Shigeo ^a,d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^c YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PROTEIN KINASE C IOTA; PROTEIN KINASE C LAMBDA; UFT; UVOMORULIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL NEOPLASMS; ISOENZYMES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEIN KINASE C; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 74649083141     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0708-x     Document Type: Article

References (46)

1. A Jemal R Siegel E Ward MJ Thun 2006 Cancer Statistics, 2006 CA Cancer J Clin. 56 106 130 10.3322/canjclin.56.2.106 16514137
2. DE Henson C Dittus M Younes H Nguyen J Albores-Saavedra 2004 Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type Arch Pathol Lab Med 128 765 770 15214826
3. SC Cunningham F Kamangar MP Kim, et al. 2005 Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution J Gastrointest Surg 9 718 725 10.1016/j.gassur.2004.12.002 15862270 (Pubitemid 40603013)
4. J Faycal C Bessaguet JB Nousbaum, et al. 2005 Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995 Gastroenterol Clin Biol. 29 23 32 15738892
5. Y Tsubono S Hisamichi 2000 Screening for gastric cancer in Japan Gastric Cancer 3 9 18 10.1007/PL00011692 11984703
6. W Koizumi H Narahara T Hara, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
7. JA Ajani 2008 Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen Cancer 113 945 955 10.1002/cncr.23661 1:CAS:528:DC%2BD1cXhtFSlur3E 18623382
8. Y Nishizuka 1995 Protein kinase C and lipid signaling for sustained cellular responses FASEB J 9 484 496 1:CAS:528:DyaK2MXlsVOqurk%3D 7737456
9. A Suzuki K Akimoto S Ohno 2003 Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms J Biochem 133 9 16 10.1093/jb/mvg018 1:CAS:528:DC%2BD3sXitlOkurc%3D 12761193 (Pubitemid 36240973)
10. K Akimoto K Mizuno S Osada, et al. 1994 A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells J Biol Chem 269 12677 12683 1:CAS:528:DyaK2cXktVeksL8%3D 7513693
11. S Ohno 2001 Intercellular junctions and cellular polarity: the Par-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity Curr Opin Cell Biol 13 641 648 10.1016/S0955-0674(00)00264-7 1:CAS:528:DC%2BD3MXmsFersbk%3D 11544035 (Pubitemid 32817025)
12. L Jamieson L Carpenter TJ Biden AP Fields 1999 Protein kinase C iota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis J Biol Chem 274 3927 3930 10.1074/jbc.274.7.3927 1:CAS:528:DyaK1MXhslahtL0%3D 9933579 (Pubitemid 29090914)
13. S Etienne-Manneville A Hall 2003 Cell polarity: Par6, aPKC and cytoskeletal crosstalk Curr Opin Cell Biol 1 67 72 10.1016/S0955-0674(02)00005-4 (Pubitemid 36044717)
14. J Moscat MT Diaz-Meco 2000 The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters EMBO Rep 1 399 403 10.1093/embo-reports/kvd098 1:CAS:528:DC%2BD3MXjtF2hsLs%3D 11258478
15. K Akimoto R Takahashi S Moriya, et al. 1996 EGF or PDGF receptors activate atypical PKC lambda through phosphatidylinositol 3-kinase EMBO J 15 788 798 1:CAS:528:DyaK28XhsFGgt7k%3D 8631300
16. K Akimoto M Nakaya T Yamanaka, et al. 1998 Atypical protein kinase C lambda binds and regulates p70 S6 kinase Biochem J 335 417 424 1:CAS:528:DyaK1cXntFWntbY%3D 9761742
17. J Moscat MT Diaz-Meco A Albert S Campuzano 2006 Cell signaling and function organized by PB1 domain interactions Mol Cell 23 631 640 10.1016/j.molcel.2006.08.002 1:CAS:528:DC%2BD28XhtVSkt73E 16949360 (Pubitemid 44292560)
18. RP Regala C Weems L Jamieson JA Copland EA Thompson AP Fields 2005 Atypical protein kinase C ι plays a critical role in human lung cancer cell growth and tumorigenicity J Biol Chem. 280 31109 31115 10.1074/jbc.M505402200 1:CAS:528:DC%2BD2MXpsVCmtbg%3D 15994303 (Pubitemid 41291846)
19. PR Roderick W Capella J Lee, et al. 2005 Atypical protein kinase C ι is an oncogene in human non-small cell lung cancer Cancer Res 65 8905 8911 10.1158/0008-5472.CAN-05-2372 (Pubitemid 41377380)
20. W Weichert V Gekeler C Denkert M Dietel S Hauptmann 2003 Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis Int J Oncol 23 633 639 1:CAS:528:DC%2BD3sXntVCjsLk%3D 12888898
21. AM Eder X Sui DG Rosen, et al. 2005 Atypical PKC iota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer Proc Natl Acad Sci U S A. 102 12519 12524 10.1073/pnas.0505641102 1:CAS:528:DC%2BD2MXhtVSjsrrF 16116079 (Pubitemid 41266391)
22. L Zhang J Huang N Yang, et al. 2006 Integrative genomic analysis of protein kinase C (PKC) family identifies PKC iota as a biomarker and potential oncogene in ovarian carcinoma Cancer Res 66 4627 4635 10.1158/0008-5472.CAN-05- 4527 1:CAS:528:DC%2BD28XjvF2ksLc%3D 16651413
23. NR Murray L Jamieso W Yu, et al. 2004 Protein kinase C iota is required for Ras transformation and colon carcinogenesis in vivo J Cell Biol 164 797 802 10.1083/jcb.200311011 1:CAS:528:DC%2BD2cXitleqs7g%3D 15024028 (Pubitemid 38366891)
24. Q Li JM Wang C Liu BL Xiao JX Lu SQ Zou 2008 Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma Hepatobiliary Pancreat Dis Int 7 70 75 18234642
25. Y Kojima K Akimoto Y Nagashima, et al. 2008 The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors Hum Pathol 39 824 831 10.1016/j.humpath.2007.11.001 1:CAS:528:DC%2BD1cXmvFemuro%3D 18538170 (Pubitemid 351758943)
26. C Yeaman KK Grindstaff WJ Nelson 1999 New perspectives on mechanisms involved in generating epithelial cell polarity Physiol Rev 79 73 98 1:CAS:528:DyaK1MXhs1Cgu70%3D 9922368
27. TT Onder PB Gupta SA Mani J Yang ES Lander RA Weinberg 2008 Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res 68 3645 3654 10.1158/0008-5472.CAN-07-2938 1:CAS:528: DC%2BD1cXlvVOitLw%3D 18483246
28. A Jawhari S Johnson S Poole P Browne M Pignatelli MJ Farthing 1997 Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patients survival Gastroenterology 112 46 54 10.1016/S0016-5085(97)70218-X 1:STN:280:DyaK2s7jt12rsQ%3D%3D 8978342
29. Y Yonemura Y Endou K Kimura, et al. 2000 Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer Clin Cancer Res. 6 4234 4242 1:CAS:528:DC%2BD3cXovVSgtbg%3D 11106237
30. Y Shimada S Yamasaki Y Hashimoto, et al. 2004 Clinical significance of dysadherin expression in gastric cancer patients Clin Cancer Res. 10 2818 2823 10.1158/1078-0432.CCR-0633-03 1:CAS:528:DC%2BD2cXjt1Cltbc%3D 15102690 (Pubitemid 38509161)
31. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Lyon: IARCP Press; 2000. p. 39-52.
32. Sobin LH, Wittekind, CH. TNM: classification of malignant tumours, 6th edn. The International Union against Cancer (UICC); 2003.
33. A Suzuki C Ishiyama K Hashiba M Shimizu K Ebnet S Ohno 2002 aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization J Cell Sci 115 3565 3573 10.1242/jcs.00032 1:CAS:528:DC%2BD38XnvFGns7o%3D 12186943
34. T Yamanaka Y Horikoshi A Suzuki, et al. 2001 PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex Genes Cells 6 721 731 10.1046/j.1365-2443.2001. 00453.x 1:CAS:528:DC%2BD3MXms1Sltbw%3D 11532031 (Pubitemid 32791683)
35. A Suzuki S Ohno 2006 The PAR-aPKC system: lessons in polarity J Cell Sci 119 979 987 10.1242/jcs.02898 1:CAS:528:DC%2BD28Xjs1yrsbo%3D 16525119
36. F Uberall K Hellbert S Kampfer, et al. 1999 Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton J Cell Biol 144 413 425 10.1083/jcb.144.3.413 1:CAS:528:DyaK1MXhtFGru74%3D 9971737 (Pubitemid 29234522)
37. S Kampfer M Windegger F Hochholdinger W Schwaiger RG Pestell G Baier, et al. 2001 Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras J Biol Chem 276 42834 42842 10.1074/jbc.M102047200 1:CAS:528:DC%2BD3MXptlelsrg%3D 11551901
38. NR Murray L Jamieson W Yu, et al. 2004 Protein kinase C iota is required for Ras transformation and colon carcinogenesis in vivo J Cell Biol 164 797 802 10.1083/jcb.200311011 1:CAS:528:DC%2BD2cXitleqs7g%3D 15024028 (Pubitemid 38366891)
39. Y Shino A Watanabe Y Yamada, et al. 1995 Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas Cancer 76 2193 2201 10.1002/1097-0142(19951201)76:11<2193::AID-CNCR2820761104>3.0. CO;2-2 1:STN:280:DyaK283itlaksg%3D%3D 8635021
40. A Ougolkov K Yamashita V Bilim Y Takahashi M Mai T Minamoto 2003 Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis Int J Colorectal Dis 18 160 166 12548420
41. Y Lu L Jamieson AR Brasier AP Fields 2001 NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival Oncogene 20 4777 4792 10.1038/sj.onc.1204607 1:CAS:528:DC%2BD3MXmtlCrsL0%3D 11521190 (Pubitemid 32803149)
42. M Dean T Fojo S Bates 2005 Tumour stem cells and drug resistance Nat Rev Cancer 5 275 284 10.1038/nrc1590 1:CAS:528:DC%2BD2MXivVarsL4%3D 15803154 (Pubitemid 40488633)
43. AP Fields RP Regala 2007 Protein kinase C iota: human oncogene, prognostic marker and therapeutic target Pharmacol Res 55 487 497 10.1016/j.phrs.2007.04.015 1:CAS:528:DC%2BD2sXntFyhtrc%3D 17570678 (Pubitemid 46962307)
44. RP Regala EA Thompson AP Fields 2008 Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells Cancer Res 68 5888 5895 10.1158/0008-5472.CAN-08-0438 1:CAS:528:DC%2BD1cXovVCnsbk%3D 18632643
45. AP Fields NR Murray 2008 Protein kinase C isozymes as therapeutic targets for treatment of human cancers Adv Enzyme Regul 48 166 178 10.1016/j.advenzreg. 2007.11.014 1:CAS:528:DC%2BD1MXhsFGmtbrP 18167314
46. M Stallings-Mann L Jamieson RP Regala C Weems NR Murray AP Fields 2006 A novel small-molecule inhibitor of protein kinase C iota blocks transformed growth of non-small-cell lung cancer cells Cancer Res 66 1767 1774 10.1158/0008-5472.CAN-05-3405 1:CAS:528:DC%2BD28XpsVeltw%3D%3D 16452237 (Pubitemid 43259962)